Genmab A/S (GMAB) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Genmab A/S - American Depositary Shares (GMAB)
Company Research
Source: Seeking Alpha
Jan van de Winkel - Co-Founder, President & CEO Brad Bailey Anthony Pagano - Executive VP & CFO Tahamtan Ahmadi - Executive VP, Chief Medical Officer & Head of Experimental Medicines Judith Klimovsky - Executive VP & Chief Development Officer Conference Call Participants Jonathan Chang - Leerink Partners LLC, Research Division Asthika Goonewardene - Truist Securities, Inc., Research Division Xian Deng - UBS Investment Bank, Research Division Rajan Sharma - Goldman Sachs Group, Inc., Research Division Judah Frommer - Morgan Stanley, Research Division James Gordon - Barclays Bank PLC, Research Division Zain Ebrahim - JPMorgan Chase & Co, Research Division Suzanne van Voorthuizen Yaron Werber - TD Cowen, Research Division Qize Ding - Rothschild & Co Redburn, Research Division Matthew Phipps - William Blair & Company L.L.C., Research Division Victor Floch - BNP Paribas, Research Division Mattias Häggblom - Handelsbanken Capital Markets AB, Research Div
Show less
Read more
Impact Snapshot
Event Time:
GMAB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GMAB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GMAB alerts
High impacting Genmab A/S - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
GMAB
News
- Notice to Convene the Annual General Meeting of Genmab A/S [Yahoo! Finance]Yahoo! Finance
- Genmab A/S (NASDAQ:GMAB) had its price target raised by analysts at HC Wainwright from $39.00 to $40.00. They now have a "buy" rating on the stock.MarketBeat
- Genmab Publishes 2025 Annual ReportGlobeNewswire
- Genmab A/S (NASDAQ:GMAB) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $41.50 price target on the stock.MarketBeat
- AbbVie: Dominating Immunology While Building Oncology Upside [Seeking Alpha]Seeking Alpha